Safety Data on Hepatitis B Vaccine for Newborns ‘Sadly Lacking’

The U.S. Food and Drug Administration approved Recombivax HB, the hepatitis B vaccine for newborns, based on clinical trials performed on only 147 infants and children who were monitored for just five days.

This post was created with our nice and easy submission form. Create your post!



What do you think?

Posted by Chris10

Researchers Link Glyphosate-Based Weedkillers to Liver Disease and Endocrine Disorders in Kids

‘Flagrant, In-Your-Face Corruption’ Led to Ohio Train Disaster, David Sirota Tells RFK, Jr.